Chinese made-in-India fakes seized by regulators

India, with help from Nigeria, has made one of its largest scores this year of Chinese-origin "Made in India" fakes: about $220,000 of VS International's antibiotic Ciprotab. The counterfeits, which contained little or no API, traveled through Frankfurt to Nigeria, where they were seized by regulators. Article

Suggested Articles

Manufacturing

Concern for drug shortages grows as COVID-19 outbreak drags on

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

by Eric Palmer
Pills in pill container
Pharma Asia

Coronavirus poses threats to brand demand and generic supply

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

by Angus Liu
A closeup of a stock market ticker
Manufacturing

Manufacturing News of Note—WuXi Biologics restarts China sites

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.